Automated Analyzers Market | Industry Growth and Trend Analysis (2024-2032)

Automated Analyzers Market Synopsis:

Automated Analyzers Market Size Was Valued at USD 2.89 Billion in 2023, and is Projected to Reach USD 6.76 Billion by 2032, Growing at a CAGR of 9.9% From 2024-2032.

The Automated Analyzers Market relates to the international market for analytical devices that can independently perform diagnostic tests in lab, clinics, and hospitals. These analyzers help to assume the repetitive roles of the analyses which are efficient and much more accurate in the rapid throughput circumstances.

Automated analyzers prove useful in modern healthcare settings due to the contribution within the context of optimizing diagnostic performance. These devices help in analyzing patient samples including blood, urine and tissues samples thereby minimizing on human input and speeds up on the results that are very vital for the patient. The frequency of chronic diseases is growing and with it is demand for each automated analyzers especially in clinical laboratories where high-throughput systems are particularly important. The market is diverse in terms of products and usage where all form and are affected by technology advancements such as artificial intelligence and machine learning which enhances analytics peculiar suited for predictive diagnosis.

It should be noted that the scope of the market dynamically affects different applications such as oncology, cardiology, infectious diseases and endocrinology, due to the great importance of the exact diagnostics of the disease type. Automated analyzers are not exclusive to large hospitals; they are also becoming popular in smaller clinics and point to care settings, making their usage conventional. This market is further propelled by the rising spending on health care around the world as well as rising knowledge regarding the advantages of early detection of diseases. However, the cost of implementing these systems, and the requirement for professionally trained personnel to run them, are concerns in low-resource environments. However, reporting continues to improve, and as more models becomes more affordable and easier to use, its market will steadily grow in years to come.

Automated Analyzers Market Trend Analysis:

Rising Demand for Portable and Point-of-Care Analyzers

• The portable and point-of-care (POC) automated analyzers market is emerging because the health industry is moving towards decentralization and person-centeredness. Point-of-care devices allow for quicker identification across different environments, including the countryside, and deliver more timely information to complement very timely decisions more frequently in emergent states. These devices are gaining enhancements in miniaturization and wireless communication technology make these devices accurate and efficient that have been filling the gaps in health care clinics leading to improved patient outcomes achieved through the ability of the devices to perform diagnostics at the point of care.
• Furthermore, new, portable, simple, and easy-to-use POC analyzers are being developed and adopted by health care providers seeking to offload some lab work. These analyzers enable small health care centres and clinics to afford to perform many different tests without requiring large laboratories. Their convenience and high rate of performance make them valuable in urgent cases and in the treatment of chronic processes, thus becoming a strategic tool for the development of the market for automated analyzers.

Integration of Artificial Intelligence for Enhanced Diagnostics

• The use of artificial intelligence in automated analyzers opens up the market development’s prospects in terms of enhancing diagnostic accuracy and speed. Data abstraction by these devices can be effectively handled by AI algorithms where large volumes of data are produced by the devices and may require special analysis which may not be feasible by the human operators. This capability can save significant amount of time as compared to traditional models in difficult to diagnose specialties like oncology or cardiology where early morbidity identification is of paramount importance. That means AI-powered analyzers may help healthcare providers make correct and prompt decisions regarding patients’ treatment.
• Furthermore, the integration of AI increases the flexibility and practicality of the automated analyzers so that they may address various diagnostic requirements in various contexts. Some of the newer analytic software are AI shaped and they are quickly finding market with healthcare providers seeking to enhance on further precise diagnostic methods which if employed effectively help lower overall medical expenses due to preventive measures as opposed to proactive. With technological development, AI may enhance the position of the automated analyzer not only in terms of higher precision but also the areas it can cover in the healthcare field.

Automated Analyzers Market Segment Analysis:

Automated Analyzers Market is Segmented on the basis of Product Type, Technology, Application, End User, and Region

By Product Type, Clinical Chemistry Analyzers segment is expected to dominate the market during the forecast period

• The current line of products in the automated analyzers market is diverse with each product designed to address the different diagnostic requirements. For instance, Clinical Chemistry Analyzers, is used for blood and urine tests which are general tests to be conducted and necessary for the analysis of chronic diseases. Hematology analyser are dedicated on blood test and are crucial in diagnosing diseases such as anemia and cancers related to blood. Immunoassay Analyzers are quite useful in markers linked with infectious diseases and hormone disorders; the two primary areas are oncology and endocrinology. MDAs are analytical instruments that offer a high level of selectivity and detectability used in genotyping and pathogen identification as the personalized medicine industry emerges.
• Both types of analyser have different specifications that meet specific clinical requirements, which are necessary for the diagnosis that healthcare facilities seek today. According to the more focus on precision medicine, the need for professional analyzers, such as molecular and immunoassay analyzers, are rising and thus boosting these product areas. Flexibility of such products also guarantees that they are always relevant in different healthcare institutions, including large hospitals and small clinics.

By Application, Oncology segment expected to held the largest share

• They are used in many applications in healthcare with oncology, cardology, infectious disease and endocrinology as the most common fields. With these analyzers, cancer markers are detected early in oncology so different measures can be taken that can have an effect on the results of the patient. Cardiology applications use fully automatic analyzers for the detection of cardiac markers, to help to diagnose and treat heart diseases. Automated analyzers have become particularly relevant to infectious diseases since the COVID-19 outbreak, mainly due to the need for rapid diagnostics in diseases management and prevention.
• Automated analyzers are also used in the endocrinology applications like; Hormones monitoring and the management of some diseases such as diabetes. Such a wide applicability makes clear the role of automated analyzers in improving the diagnostic potential in different branches of healthcare. Thus, their use in various fields guarantees that the devices remain indispensable not only for everyday practice but also for various specialized approaches necessary to diagnose different pathologies in patients.

Automated Analyzers Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• North America is another major market in the automated analyzers market due to its well-developed healthcare system and previously higher incidence of technology adoption. The existence of a large number of important market players and increased spending on healthcare also contributed to the reinforcement of North American status in this market. These are the factors such as high awareness of the healthcare providers regarding the utility of the automatic analyzers and government support policies to back up the growth and development of healthcare. This saves costs and time of the consumer in the region and also helps in promoting growth and development of the market because the regulatory framework provides quality and efficient medical devices for use in treatment.
• Further, the precise diagnostic solutions are in great demand in North America due to the higher geriatric population and a higher prevalence of chronic diseases. All these contribute towards making it possible for the automated analyzers not only to be embraced, but to become an essential tool in health care. Rising need for fast and accurate diagnosis will enable the North America automated analyzers market to retain its supremacy.

Active Key Players in the Automated Analyzers Market:

• Abbott Laboratories (USA)
• Danaher Corporation (USA)
• Siemens Healthineers (Germany)
• Thermo Fisher Scientific (USA)
• Roche Diagnostics (Switzerland)
• Sysmex Corporation (Japan)
• Bio-Rad Laboratories (USA)
• Horiba, Ltd. (Japan)
• Mindray Medical International Limited (China)
• Beckman Coulter, Inc. (USA)
• Agilent Technologies (USA)
• Ortho Clinical Diagnostics (USA)
• Other Active Players

Key Industry Developments in the Automated Analyzers Market:

• On January 2024, Beckman Coulter, Inc., one of the clinical diagnostics leaders and a subsidiary of Danaher, launched the DXC 500 AU Chemistry Analyzer, an automated clinical chemistry analyzer, at Medlab Middle East in Dubai, held on February 5-8, 2024. The DxC 500 AU Chemistry Analyzer features advanced automation technology, onboard guided workflows, and standardized reagents for use across healthcare networks.
• On January 2024, HORIBA, Ltd., a medical device company, launched 2.0 high throughput automated hematology that offers a highly flexible and efficient modular hematology solution that is fully scalable with many possible configurations for mid to large-scale laboratories
• In November 2023, CANON MEDICAL SYSTEMS CORPORATION, a medical device company, held a ceremony at its Dalian plant in Liaoning province, China, to mark the domestic production of its TBA-FX8 fully automated biochemistry analyzer, which was approved for sale in China in June 2023. Equipped with V2.0 software, TBA-FX8 can achieve automatic quality control of multiple sets of reagents at the same time, and support the early warning of the reaction curve, thus, helping inspectors to quickly analyze abnormal results, and find the cause of the problem, and assess the status of the instrument.
• In November 2023, the Embassy of the Republic of Korea (RoK) donated Fully Automated Biochemistry Analyzers, valued at US$ 402,500, to Nepal. The official handover ceremony took place at the Ministry of Health and Population, Government of Nepal, in the presence of Dr. Roshan Pokhrel, Secretary of the Ministry of Health and Population of Nepal and Mr. Park Tae-Young, the Ambassador of the Republic of Korea to Nepal. Secretary Pokhrel accepted the donation on behalf of the Nepalese government.

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Automated Analyzers Market by Product Type
 4.1 Automated Analyzers Market Snapshot and Growth Engine
 4.2 Automated Analyzers Market Overview
 4.3 Clinical Chemistry Analyzers
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Clinical Chemistry Analyzers: Geographic Segmentation Analysis
 4.4 Hematology Analyzers
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Hematology Analyzers: Geographic Segmentation Analysis
 4.5 Immunoassay Analyzers
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Immunoassay Analyzers: Geographic Segmentation Analysis
 4.6 Molecular Diagnostics Analyzers
  4.6.1 Introduction and Market Overview
  4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.6.3 Key Market Trends, Growth Factors and Opportunities
  4.6.4 Molecular Diagnostics Analyzers: Geographic Segmentation Analysis
 4.7 Others
  4.7.1 Introduction and Market Overview
  4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.7.3 Key Market Trends, Growth Factors and Opportunities
  4.7.4 Others: Geographic Segmentation Analysis

Chapter 5: Automated Analyzers Market by Technology
 5.1 Automated Analyzers Market Snapshot and Growth Engine
 5.2 Automated Analyzers Market Overview
 5.3 Immunoassay Clinical Chemistry
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Immunoassay Clinical Chemistry: Geographic Segmentation Analysis
 5.4 Molecular Diagnostics
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Molecular Diagnostics: Geographic Segmentation Analysis
 5.5 Hematology
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Hematology: Geographic Segmentation Analysis
 5.6 Microbiology
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Microbiology: Geographic Segmentation Analysis

Chapter 6: Automated Analyzers Market by Application
 6.1 Automated Analyzers Market Snapshot and Growth Engine
 6.2 Automated Analyzers Market Overview
 6.3 Oncology
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Oncology: Geographic Segmentation Analysis
 6.4 Cardiology
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Cardiology: Geographic Segmentation Analysis
 6.5 Infectious Diseases
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Infectious Diseases: Geographic Segmentation Analysis
 6.6 Endocrinology
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Endocrinology: Geographic Segmentation Analysis
 6.7 Others
  6.7.1 Introduction and Market Overview
  6.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.7.3 Key Market Trends, Growth Factors and Opportunities
  6.7.4 Others: Geographic Segmentation Analysis

Chapter 7: Automated Analyzers Market by End User
 7.1 Automated Analyzers Market Snapshot and Growth Engine
 7.2 Automated Analyzers Market Overview
 7.3 Hospitals
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Hospitals: Geographic Segmentation Analysis
 7.4 Diagnostic Laboratories
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Diagnostic Laboratories: Geographic Segmentation Analysis
 7.5 Research Institutes
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Research Institutes: Geographic Segmentation Analysis
 7.6 Others
  7.6.1 Introduction and Market Overview
  7.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.6.3 Key Market Trends, Growth Factors and Opportunities
  7.6.4 Others: Geographic Segmentation Analysis

Chapter 8: Company Profiles and Competitive Analysis
 8.1 Competitive Landscape
  8.1.1 Competitive Benchmarking
  8.1.2 Automated Analyzers Market Share by Manufacturer (2023)
  8.1.3 Industry BCG Matrix
  8.1.4 Heat Map Analysis
  8.1.5 Mergers and Acquisitions  
 8.2 ABBOTT LABORATORIES (USA)
  8.2.1 Company Overview
  8.2.2 Key Executives
  8.2.3 Company Snapshot
  8.2.4 Role of the Company in the Market
  8.2.5 Sustainability and Social Responsibility
  8.2.6 Operating Business Segments
  8.2.7 Product Portfolio
  8.2.8 Business Performance
  8.2.9 Key Strategic Moves and Recent Developments
  8.2.10 SWOT Analysis
 8.3 DANAHER CORPORATION (USA)
 8.4 SIEMENS HEALTHINEERS (GERMANY)
 8.5 THERMO FISHER SCIENTIFIC (USA)
 8.6 ROCHE DIAGNOSTICS (SWITZERLAND)
 8.7 SYSMEX CORPORATION (JAPAN)
 8.8 BIO-RAD LABORATORIES (USA)
 8.9 HORIBA
 8.10 LTD. (JAPAN)
 8.11 MINDRAY MEDICAL INTERNATIONAL LIMITED (CHINA)
 8.12 BECKMAN COULTER INC. (USA)
 8.13 AGILENT TECHNOLOGIES (USA)
 8.14 ORTHO CLINICAL DIAGNOSTICS (USA)
 8.15 OTHER ACTIVE PLAYERS

Chapter 9: Global Automated Analyzers Market By Region
 9.1 Overview
 9.2. North America Automated Analyzers Market
  9.2.1 Key Market Trends, Growth Factors and Opportunities
  9.2.2 Top Key Companies
  9.2.3 Historic and Forecasted Market Size by Segments
  9.2.4 Historic and Forecasted Market Size By Product Type
  9.2.4.1 Clinical Chemistry Analyzers
  9.2.4.2 Hematology Analyzers
  9.2.4.3 Immunoassay Analyzers
  9.2.4.4 Molecular Diagnostics Analyzers
  9.2.4.5 Others
  9.2.5 Historic and Forecasted Market Size By Technology
  9.2.5.1 Immunoassay Clinical Chemistry
  9.2.5.2 Molecular Diagnostics
  9.2.5.3 Hematology
  9.2.5.4 Microbiology
  9.2.6 Historic and Forecasted Market Size By Application
  9.2.6.1 Oncology
  9.2.6.2 Cardiology
  9.2.6.3 Infectious Diseases
  9.2.6.4 Endocrinology
  9.2.6.5 Others
  9.2.7 Historic and Forecasted Market Size By End User
  9.2.7.1 Hospitals
  9.2.7.2 Diagnostic Laboratories
  9.2.7.3 Research Institutes
  9.2.7.4 Others
  9.2.8 Historic and Forecast Market Size by Country
  9.2.8.1 US
  9.2.8.2 Canada
  9.2.8.3 Mexico
 9.3. Eastern Europe Automated Analyzers Market
  9.3.1 Key Market Trends, Growth Factors and Opportunities
  9.3.2 Top Key Companies
  9.3.3 Historic and Forecasted Market Size by Segments
  9.3.4 Historic and Forecasted Market Size By Product Type
  9.3.4.1 Clinical Chemistry Analyzers
  9.3.4.2 Hematology Analyzers
  9.3.4.3 Immunoassay Analyzers
  9.3.4.4 Molecular Diagnostics Analyzers
  9.3.4.5 Others
  9.3.5 Historic and Forecasted Market Size By Technology
  9.3.5.1 Immunoassay Clinical Chemistry
  9.3.5.2 Molecular Diagnostics
  9.3.5.3 Hematology
  9.3.5.4 Microbiology
  9.3.6 Historic and Forecasted Market Size By Application
  9.3.6.1 Oncology
  9.3.6.2 Cardiology
  9.3.6.3 Infectious Diseases
  9.3.6.4 Endocrinology
  9.3.6.5 Others
  9.3.7 Historic and Forecasted Market Size By End User
  9.3.7.1 Hospitals
  9.3.7.2 Diagnostic Laboratories
  9.3.7.3 Research Institutes
  9.3.7.4 Others
  9.3.8 Historic and Forecast Market Size by Country
  9.3.8.1 Russia
  9.3.8.2 Bulgaria
  9.3.8.3 The Czech Republic
  9.3.8.4 Hungary
  9.3.8.5 Poland
  9.3.8.6 Romania
  9.3.8.7 Rest of Eastern Europe
 9.4. Western Europe Automated Analyzers Market
  9.4.1 Key Market Trends, Growth Factors and Opportunities
  9.4.2 Top Key Companies
  9.4.3 Historic and Forecasted Market Size by Segments
  9.4.4 Historic and Forecasted Market Size By Product Type
  9.4.4.1 Clinical Chemistry Analyzers
  9.4.4.2 Hematology Analyzers
  9.4.4.3 Immunoassay Analyzers
  9.4.4.4 Molecular Diagnostics Analyzers
  9.4.4.5 Others
  9.4.5 Historic and Forecasted Market Size By Technology
  9.4.5.1 Immunoassay Clinical Chemistry
  9.4.5.2 Molecular Diagnostics
  9.4.5.3 Hematology
  9.4.5.4 Microbiology
  9.4.6 Historic and Forecasted Market Size By Application
  9.4.6.1 Oncology
  9.4.6.2 Cardiology
  9.4.6.3 Infectious Diseases
  9.4.6.4 Endocrinology
  9.4.6.5 Others
  9.4.7 Historic and Forecasted Market Size By End User
  9.4.7.1 Hospitals
  9.4.7.2 Diagnostic Laboratories
  9.4.7.3 Research Institutes
  9.4.7.4 Others
  9.4.8 Historic and Forecast Market Size by Country
  9.4.8.1 Germany
  9.4.8.2 UK
  9.4.8.3 France
  9.4.8.4 The Netherlands
  9.4.8.5 Italy
  9.4.8.6 Spain
  9.4.8.7 Rest of Western Europe
 9.5. Asia Pacific Automated Analyzers Market
  9.5.1 Key Market Trends, Growth Factors and Opportunities
  9.5.2 Top Key Companies
  9.5.3 Historic and Forecasted Market Size by Segments
  9.5.4 Historic and Forecasted Market Size By Product Type
  9.5.4.1 Clinical Chemistry Analyzers
  9.5.4.2 Hematology Analyzers
  9.5.4.3 Immunoassay Analyzers
  9.5.4.4 Molecular Diagnostics Analyzers
  9.5.4.5 Others
  9.5.5 Historic and Forecasted Market Size By Technology
  9.5.5.1 Immunoassay Clinical Chemistry
  9.5.5.2 Molecular Diagnostics
  9.5.5.3 Hematology
  9.5.5.4 Microbiology
  9.5.6 Historic and Forecasted Market Size By Application
  9.5.6.1 Oncology
  9.5.6.2 Cardiology
  9.5.6.3 Infectious Diseases
  9.5.6.4 Endocrinology
  9.5.6.5 Others
  9.5.7 Historic and Forecasted Market Size By End User
  9.5.7.1 Hospitals
  9.5.7.2 Diagnostic Laboratories
  9.5.7.3 Research Institutes
  9.5.7.4 Others
  9.5.8 Historic and Forecast Market Size by Country
  9.5.8.1 China
  9.5.8.2 India
  9.5.8.3 Japan
  9.5.8.4 South Korea
  9.5.8.5 Malaysia
  9.5.8.6 Thailand
  9.5.8.7 Vietnam
  9.5.8.8 The Philippines
  9.5.8.9 Australia
  9.5.8.10 New Zealand
  9.5.8.11 Rest of APAC
 9.6. Middle East & Africa Automated Analyzers Market
  9.6.1 Key Market Trends, Growth Factors and Opportunities
  9.6.2 Top Key Companies
  9.6.3 Historic and Forecasted Market Size by Segments
  9.6.4 Historic and Forecasted Market Size By Product Type
  9.6.4.1 Clinical Chemistry Analyzers
  9.6.4.2 Hematology Analyzers
  9.6.4.3 Immunoassay Analyzers
  9.6.4.4 Molecular Diagnostics Analyzers
  9.6.4.5 Others
  9.6.5 Historic and Forecasted Market Size By Technology
  9.6.5.1 Immunoassay Clinical Chemistry
  9.6.5.2 Molecular Diagnostics
  9.6.5.3 Hematology
  9.6.5.4 Microbiology
  9.6.6 Historic and Forecasted Market Size By Application
  9.6.6.1 Oncology
  9.6.6.2 Cardiology
  9.6.6.3 Infectious Diseases
  9.6.6.4 Endocrinology
  9.6.6.5 Others
  9.6.7 Historic and Forecasted Market Size By End User
  9.6.7.1 Hospitals
  9.6.7.2 Diagnostic Laboratories
  9.6.7.3 Research Institutes
  9.6.7.4 Others
  9.6.8 Historic and Forecast Market Size by Country
  9.6.8.1 Turkiye
  9.6.8.2 Bahrain
  9.6.8.3 Kuwait
  9.6.8.4 Saudi Arabia
  9.6.8.5 Qatar
  9.6.8.6 UAE
  9.6.8.7 Israel
  9.6.8.8 South Africa
 9.7. South America Automated Analyzers Market
  9.7.1 Key Market Trends, Growth Factors and Opportunities
  9.7.2 Top Key Companies
  9.7.3 Historic and Forecasted Market Size by Segments
  9.7.4 Historic and Forecasted Market Size By Product Type
  9.7.4.1 Clinical Chemistry Analyzers
  9.7.4.2 Hematology Analyzers
  9.7.4.3 Immunoassay Analyzers
  9.7.4.4 Molecular Diagnostics Analyzers
  9.7.4.5 Others
  9.7.5 Historic and Forecasted Market Size By Technology
  9.7.5.1 Immunoassay Clinical Chemistry
  9.7.5.2 Molecular Diagnostics
  9.7.5.3 Hematology
  9.7.5.4 Microbiology
  9.7.6 Historic and Forecasted Market Size By Application
  9.7.6.1 Oncology
  9.7.6.2 Cardiology
  9.7.6.3 Infectious Diseases
  9.7.6.4 Endocrinology
  9.7.6.5 Others
  9.7.7 Historic and Forecasted Market Size By End User
  9.7.7.1 Hospitals
  9.7.7.2 Diagnostic Laboratories
  9.7.7.3 Research Institutes
  9.7.7.4 Others
  9.7.8 Historic and Forecast Market Size by Country
  9.7.8.1 Brazil
  9.7.8.2 Argentina
  9.7.8.3 Rest of SA

Chapter 10 Analyst Viewpoint and Conclusion
10.1 Recommendations and Concluding Analysis
10.2 Potential Market Strategies

Chapter 11 Research Methodology
11.1 Research Process
11.2 Primary Research
11.3 Secondary Research